seen from China
seen from United States
seen from Romania
seen from Japan
seen from Japan
seen from Germany
seen from Germany
seen from Türkiye
seen from United States
seen from United States
seen from China
seen from United States
seen from Türkiye
seen from United States
seen from China
seen from Australia
seen from United States
seen from Sweden
seen from Russia
seen from United States
Ixazomib - a selective and reversible inhibitor of the protein proteasome subunit beta type-5 (PSMB5) similar to bortezomib. It contains leucine derivative with the carboxylate acid replaced by a boronic acid. It is used for the treatment of multiple myeloma together with daratumumab and elotuzumab.
